Spotlight on hereditary cancer research studies
October 24, 2023
This expert-led panel discusses the latest in hereditary cancer research, experimental therapies, and drug developments.
Dr. Kathryn Pennington is a board-certified Gynecologic Oncologist and Associate Professor at the University of Washington, in Seattle, WA. She cares for patients both at risk for and with gynecologic malignancies, and her research interests include the molecular genetics of sporadic and familial ovarian cancer, gynecologic cancer survivorship, and improving outcomes through clinical trials.
Dr. Eduardo Vilar-Sanchez is a physician-scientist and a medical oncologist at The University of Texas MD Anderson Cancer Center. Dr. Vilar-Sanchez devotes his clinical expertise and practice to the care of patients and families diagnosed with hereditary gastrointestinal cancer syndromes, mainly Lynch syndrome and Familial Adenomatous Polyposis.
Anna Couvillon is a Nurse Practitioner at the Genitourinary Malignancies Branch, National Cancer Institute at the NIH. She is the Lead Associate Investigator for the Natural History Study of Men at High Genetic Risk for Prostate Cancer and the coordinator of the Prostate Cancer Multidisciplinary Clinic.
Survivors, previvors, caregivers and healthcare professionals.